Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Treatment of ZX008 (Fenfluramine Hydrochloride) in Pediatric and Adult Epilepsy Patients (Ages 4-25) With Sunflower Syndrome.

NCT03790137 is registered in ClinicalTrials.gov with Elizabeth Anne Thiele as lead sponsor.

NCT NCT03790137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03790137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Treatment of ZX008 (Fenfluramine Hydrochloride) in Pediatric and Adult Epilepsy Patients (Ages 4-25) With Sunflower Syndrome.
Lead sponsor
Elizabeth Anne Thiele
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2019
Completion date
July 19, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photosensitive epilepsy